Posters
« Back
Innovative technology that enables RNAi in difficult to transfect cells
EP22930
Poster Title: Innovative technology that enables RNAi in difficult to transfect cells
Submitted on 27 Apr 2015
Author(s): Christina Yamada, Kathryn Robinson, Allison St. Amand, Zaklina Strezoska, Greg Wardle, Anastasia Khvorova, Devin Leake
Affiliations: GE Healthcare Dharmacon, Inc.
Poster Views: 2,092
View poster »


Poster Information
Abstract: Delivery remains one of the last barriers for applying RNA interference (RNAi) in clinically relevant cell lines. Investigations at Dharmacon have led to the development of an innovative molecule for delivery in a wide variety of cell types. These modified siRNAs have been found to effectively silence target genes in cell types that are typically difficult to transfect using standard delivery methods. We present data for multiple cell types including SH-SY5Y (neuroblastoma), Jurkat (T-cells), and primary neurons. This technology, Dharmacon™ Accell™ siRNA reagents, allows for functional genomic studies in pertinent cell types. Moreover, in some instances, cells can be continuously dosed with these siRNAs, thus enabling knockdown of any target gene of interest for extended durations.Summary: Investigations at Dharmacon have led to the development of innovative siRNA molecules that can be delivered into difficult-to-transfect cells without additional lipid reagents, virus, or instruments. This technology, Accell siRNA reagents, enables gene knockdown for functional genomic studies in a wide variety of cell types. In some instances, cells can be continuously dosed with Accell siRNAs to enable target gene knockdown for extended durations.References: Report abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons